Product Information
OLANZAPINE-FLUOXETINE 3-25 MG is a generic product labeled by Endo USA Inc., priced at $3.9971 per EA under NDC 49884027711. Its NADAC has been published 618 times since Nov 28, 2013.
Strength
25; 3 mg/1; mg/1
Manufacturer
Endo USA Inc.NDC
49884027711
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FLUOXETINE HYDROCHLORIDE; OLANZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA077742On Market Since
11/26/2012
Pharmacological Classes
Price Statistics
The NADAC for OLANZAPINE-FLUOXETINE 3-25 MG has been published 618 times since Nov 28, 2013, and over the history we have for it it has declined 44.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.9971 per EA |
|---|---|
| All-time high | $8.3904 (Nov 12, 2014) |
| All-time low | $3.1040 (Aug 23, 2023) |
| 52-week high | $3.9971 |
| 52-week low | $3.6365 |
| Median price | $5.2796 |
| Average price | $5.4805 |
| Largest weekly change | +39.1% (Mar 23, 2022) |
| Weeks tracked | 618 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the olanzapine and fuoxetine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OLANZAPINE-FLUOXETINE 3-25 MG?
The current National Average Drug Acquisition Cost (NADAC) for OLANZAPINE-FLUOXETINE 3-25 MG, manufactured by Endo USA Inc., is $3.9971 per EA (NDC 49884027711), effective Jun 24, 2026.
How has the price of OLANZAPINE-FLUOXETINE 3-25 MG changed over time?
Over the history we have for it, the NADAC for OLANZAPINE-FLUOXETINE 3-25 MG has declined 44.7%. It has been tracked across 618 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for OLANZAPINE-FLUOXETINE 3-25 MG?
Since Nov 28, 2013, the NADAC for OLANZAPINE-FLUOXETINE 3-25 MG has ranged from a low of $3.1040 (Aug 23, 2023) to a high of $8.3904 (Nov 12, 2014), with a median of $5.2796 per EA.
Are there cheaper alternatives to OLANZAPINE-FLUOXETINE 3-25 MG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OLANZAPINE-FLUOXETINE 3-25 MG, so no direct lower-cost alternative is listed.
Who manufactures OLANZAPINE-FLUOXETINE 3-25 MG?
OLANZAPINE-FLUOXETINE 3-25 MG (NDC 49884027711) is labeled by Endo USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification